Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Gains from Investment Securities (2022 - 2025)

Historic Gains from Investment Securities for Prokidney (PROK) over the last 4 years, with Q3 2025 value amounting to $29.1 million.

  • Prokidney's Gains from Investment Securities rose 3177.0% to $29.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.1 million, marking a year-over-year increase of 3177.0%. This contributed to the annual value of $21.4 million for FY2024, which is 4611.55% up from last year.
  • According to the latest figures from Q3 2025, Prokidney's Gains from Investment Securities is $29.1 million, which was up 3177.0% from $30.5 million recorded in Q2 2025.
  • Over the past 5 years, Prokidney's Gains from Investment Securities peaked at $30.5 million during Q2 2025, and registered a low of $129370.0 during Q3 2022.
  • Over the past 4 years, Prokidney's median Gains from Investment Securities value was $16.5 million (recorded in 2023), while the average stood at $13.8 million.
  • Per our database at Business Quant, Prokidney's Gains from Investment Securities surged by 1331589.86% in 2023 and then soared by 2719.89% in 2024.
  • Over the past 4 years, Prokidney's Gains from Investment Securities (Quarter) stood at $826000.0 in 2022, then surged by 159.44% to $2.1 million in 2023, then soared by 930.18% to $22.1 million in 2024, then skyrocketed by 31.77% to $29.1 million in 2025.
  • Its Gains from Investment Securities was $29.1 million in Q3 2025, compared to $30.5 million in Q2 2025 and $30.4 million in Q1 2025.